Bioequivalence of Shinil Cefadroxil Capsule to Duricef Capsule (cefadroxil 500 mg)
![]() |
유호정
(서울대학교 약학대학)
최민구 (서울대학교 약학대학) 김경식 (베스티안 병원) 정석재 (서울대학교 약학대학) 심창구 (서울대학교 약학대학) |
1 | Barbhaiya, R.H., A pharmacokinetic comparison of cefadroxil and cephalexin after administmtion of 250, 500 and l000mg solution doses, Biopharm. Drus Disp., 17, 319-330(1996) DOI ScienceOn |
2 | Cho H.Y., Lee S., Moon J.D. and Lee Y.B, Biocquivalence of Hanacef Capsule to Duricef Capsulc (Ccfadroxil 500mg), J. Kor. Pharm. Sci., 32, 135-140 (2002) DOI ScienceOn |
3 | Gibaldi, M. (1991) Biopharmaceutics and Clinical Pharmaco. kinetic, 4th Ed., Lca & Febiger, Phiadelphia, USA |
4 | Lee Y.J., Kim Y.G., Lee M.G., Chung S.J., Lee M.H. and Shim C.K. (2000). Analysis of bioequivalence study using logtransformed model, Yakhakhoeji, 44(4), 308-314 |
5 | Lindgren, K. (1987). Dctcrminalion of cefadroxil in serum by high-performancc liquid chromatography with cephradine as intemal standard, J. Chromatogr., 413,347-350 DOI ScienceOn |
6 | 식품의약품 안전청 고시 제 2001-57호, 생물학적 동등성 시험기준(2001.9.5) |
![]() |